These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24236455)

  • 1. BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.
    Amet T; Byrd D; Hu N; Sun Q; Li F; Zhao Y; Hu S; Grantham A; Yu Q
    Curr Mol Med; 2014 Mar; 14(3):349-60. PubMed ID: 24236455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.
    Dafa-Berger A; Kuzmina A; Fassler M; Yitzhak-Asraf H; Shemer-Avni Y; Taube R
    Virology; 2012 Jul; 428(2):98-111. PubMed ID: 22520941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of different types of interferon on the expression of HCV replication-related microRNA].
    Chen H; Ye L; Su J; Jiang D; Li Y; Zeng J; Ruan Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):776-9. PubMed ID: 24844965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein.
    Zadeh VR; Urata S; Sakaguchi M; Yasuda J
    J Gen Virol; 2020 Jun; 101(6):573-586. PubMed ID: 32375950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.
    Pan XB; Qu XW; Jiang D; Zhao XL; Han JC; Wei L
    Antiviral Res; 2013 Apr; 98(1):54-60. PubMed ID: 23422647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.
    Lv M; Zhang B; Shi Y; Han Z; Zhang Y; Zhou Y; Zhang W; Niu J; Yu XF
    Sci Rep; 2015 Jun; 5():11736. PubMed ID: 26119070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
    Kinast V; Plociennikowska A; Anggakusuma ; Bracht T; Todt D; Brown RJP; Boldanova T; Zhang Y; Brüggemann Y; Friesland M; Engelmann M; Vieyres G; Broering R; Vondran FWR; Heim MH; Sitek B; Bartenschlager R; Pietschmann T; Steinmann E
    J Hepatol; 2020 Sep; 73(3):549-558. PubMed ID: 32294532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.
    Pillai SK; Abdel-Mohsen M; Guatelli J; Skasko M; Monto A; Fujimoto K; Yukl S; Greene WC; Kovari H; Rauch A; Fellay J; Battegay M; Hirschel B; Witteck A; Bernasconi E; Ledergerber B; Günthard HF; Wong JK;
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3035-40. PubMed ID: 22315404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.
    Ye L; Wang X; Li J; Liu J; Ramirez SH; Wu J; Ho W
    Innate Immun; 2012 Jun; 18(3):398-405. PubMed ID: 21940748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.
    Blanchet FP; Stalder R; Czubala M; Lehmann M; Rio L; Mangeat B; Piguet V
    Retrovirology; 2013 Jan; 10():6. PubMed ID: 23311681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?
    Andrew A; Strebel K
    J Interferon Cytokine Res; 2011 Jan; 31(1):137-44. PubMed ID: 21166593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
    Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
    J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.
    Anggakusuma ; Romero-Brey I; Berger C; Colpitts CC; Boldanova T; Engelmann M; Todt D; Perin PM; Behrendt P; Vondran FW; Xu S; Goffinet C; Schang LM; Heim MH; Bartenschlager R; Pietschmann T; Steinmann E
    Hepatology; 2015 Sep; 62(3):702-14. PubMed ID: 25999047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
    Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
    Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
    Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
    PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.